These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 24188864)
41. What is your diagnosis? Peritoneal effusion from a dog. Dell'Orco M; Bertazzolo W; Paccioretti F Vet Clin Pathol; 2009 Sep; 38(3):367-9. PubMed ID: 19351338 [TBL] [Abstract][Full Text] [Related]
42. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study. Esfandiarpour I; Dabiri SH Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170 [TBL] [Abstract][Full Text] [Related]
43. Adverse urinary effects of allopurinol in dogs with leishmaniasis. Torres M; Pastor J; Roura X; Tabar MD; Espada Y; Font A; Balasch J; Planellas M J Small Anim Pract; 2016 Jun; 57(6):299-304. PubMed ID: 27112522 [TBL] [Abstract][Full Text] [Related]
44. Granulomatous lesion on a bitch's nipple caused by Leishmania infantum. Gómez-Ochoa P; Gascón M; Aceña MC; Miana-Mena FJ; Castillo JA Vet Rec; 2005 Mar; 156(12):389. PubMed ID: 15816188 [No Abstract] [Full Text] [Related]
45. [Leishmaniasis: hospital and population-based incidence, and asymptomatic infection. A disease that is still with us]. Bellido-Blasco JB; Arnedo-Pena A; Romeo-García MA; Herrero-Carot C Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):136-7. PubMed ID: 19254647 [No Abstract] [Full Text] [Related]
46. Update on therapy and prevention of canine leishmaniasis. Apostolopoulos N; Mitropoulou A; Thom N; Moritz A Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Oct; 46(5):315-322. PubMed ID: 30541172 [TBL] [Abstract][Full Text] [Related]
47. Determination of CD4+ and CD8+ T cells in the peripheral blood of dogs with leishmaniosis before and after prolonged allopurinol monotherapy. Papadogiannakis E; Andritsos G; Kontos V; Spanakos G; Koutis C; Velonakis E Vet J; 2010 Nov; 186(2):262-3. PubMed ID: 19733103 [TBL] [Abstract][Full Text] [Related]
48. Serum ferritin and paraoxonase-1 in canine leishmaniosis. Martinez-Subiela S; Cerón JJ; Strauss-Ayali D; Garcia-Martinez JD; Tecles F; Tvarijonaviciute A; Caldin M; Baneth G Comp Immunol Microbiol Infect Dis; 2014 Jan; 37(1):23-9. PubMed ID: 24268430 [TBL] [Abstract][Full Text] [Related]
49. New delivery strategies for the old pentavalent antimonial drugs. Frézard F; Demicheli C Expert Opin Drug Deliv; 2010 Dec; 7(12):1343-58. PubMed ID: 21029028 [TBL] [Abstract][Full Text] [Related]
50. Interferon-gamma (INF-gamma), IL4 expression levels and Leishmania DNA load as prognostic markers for monitoring response to treatment of leishmaniotic dogs with miltefosine and allopurinol. Manna L; Reale S; Picillo E; Vitale F; Gravino AE Cytokine; 2008 Nov; 44(2):288-92. PubMed ID: 18842424 [TBL] [Abstract][Full Text] [Related]
51. In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs. Maia C; Nunes M; Marques M; Henriques S; Rolão N; Campino L Exp Parasitol; 2013 Sep; 135(1):36-41. PubMed ID: 23747751 [TBL] [Abstract][Full Text] [Related]
52. [Allopurinol therapy in imported dogs with leishmaniasis treated outside the endemic area]. Helm M; Müller W; Schaarschmidt D; Grimm F; Deplazes P Schweiz Arch Tierheilkd; 2013 Oct; 155(10):559-67. PubMed ID: 24091231 [TBL] [Abstract][Full Text] [Related]
53. Serum paraoxonase 1 (PON1) activity in acute pancreatitis of dogs. Tvarijonaviciute A; García-Martínez JD; Caldin M; Martínez-Subiela S; Tecles F; Pastor J; Ceron JJ J Small Anim Pract; 2015 Jan; 56(1):67-71. PubMed ID: 25395020 [TBL] [Abstract][Full Text] [Related]
54. Polyarthritis associated with visceral leishmaniasis in a juvenile dog. Santos M; Marcos R; Assunção M; Matos AJ Vet Parasitol; 2006 Nov; 141(3-4):340-4. PubMed ID: 16824686 [TBL] [Abstract][Full Text] [Related]
55. Visceral leishmaniasis and disseminated intravascular coagulation in a dog. Font A; Gines C; Closa JM; Mascort J J Am Vet Med Assoc; 1994 Apr; 204(7):1043-4. PubMed ID: 8045804 [TBL] [Abstract][Full Text] [Related]
56. Potential utility of indomethacin in enhancing the leishmanicidal activity of glucantime. Namazi MR East Mediterr Health J; 2009; 15(6):1624-5. PubMed ID: 20218157 [No Abstract] [Full Text] [Related]
57. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate. Ikeda-Garcia FA; Lopes RS; Marques FJ; de Lima VM; Morinishi CK; Bonello FL; Zanette MF; Perri SH; Feitosa MM Vet Parasitol; 2007 Feb; 143(3-4):254-9. PubMed ID: 16996214 [TBL] [Abstract][Full Text] [Related]
58. Prospective evaluation of serum pancreatic lipase immunoreactivity and troponin I concentrations in Leishmania infantum-infected dogs treated with meglumine antimonate. Xenoulis PG; Saridomichelakis MN; Chatzis MK; Kasabalis D; Petanides T; Suchodolski JS; Steiner JM Vet Parasitol; 2014 Jul; 203(3-4):326-30. PubMed ID: 24813787 [TBL] [Abstract][Full Text] [Related]
59. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol. Momeni AZ; Aminjavaheri M Eur J Dermatol; 2003; 13(1):40-3. PubMed ID: 12609780 [TBL] [Abstract][Full Text] [Related]
60. [Leishmaniasis in dogs in Germany: epidemiological case analysis and alternatives to conventional causal therapy]. Gothe R; Nolte I; Kraft W Tierarztl Prax; 1997 Jan; 25(1):68-73. PubMed ID: 9157633 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]